Annis Gardner Whiting Capital Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-489
Closed -$144K 506
2026
Q1
$144K Buy
489
+147
+43% +$43.7K 0.02% 369
2025
Q4
$93.4K Buy
342
+83
+32% +$22.6K 0.02% 419
2025
Q3
$70K Sell
259
-272
-51% -$74K 0.01% 440
2025
Q2
$146K Buy
531
+279
+111% +$75.9K 0.05% 254
2025
Q1
$66.9K Hold
252
0.03% 321
2024
Q4
$59.9K Buy
252
+15
+6% +$3.45K 0.02% 331
2024
Q3
$52.3K Sell
237
-148
-38% -$30.6K 0.01% 361
2024
Q2
$75.7K Sell
385
-16
-4% -$3.31K 0.02% 349
2024
Q1
$86.3K Buy
401
+167
+71% +$35.1K 0.03% 299
2023
Q4
$50.5K Sell
234
-9
-4% -$1.92K 0.02% 302
2023
Q3
$48.7K Buy
+243
New +$48.3K 0.03% 288

Other funds holding CME

Annis Gardner Whiting Capital Advisors's CME Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of CME Group (CME) in Q2 2026, closing a stake of 489 shares — an estimated $144K sold.

Annis Gardner Whiting Capital Advisors first reported a position in CME in Q3 2023 and held it in 11 quarters. The position peaked at $146K in Q2 2025. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 489 CME Group shares in Q2 2026, an estimated $144K.
  • Annis Gardner Whiting Capital Advisors first reported a position in CME Group in Q3 2023 and held it in 11 quarters.
  • Annis Gardner Whiting Capital Advisors's CME Group position peaked at $146K in Q2 2025.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.